RNAi Technologies and Global Markets
Report Scope
The scope of this study encompasses an investigation of the ribonucleic acid interference (RNAi) technology market. BCC Research analyzes RNAi technology based on technology type: tools and reagents, diagnostics, therapeutics, and agriculture. BCC Research determines the current market status in each segment, examines its impact on future needs, and presents growth forecasts over the next six years. The report provides a detailed analysis of the market’s drivers, restraints, challenges, and opportunities. It includes company profiles of key players, with detailed information about their business segments, financials, product portfolios, and recent developments. The report also provides detailed information on emerging technologies and new developments in the market; examines the regulatory landscape; provides a patent and pipeline analysis; and discusses ESG developments, the investment outlook, and deals within the market.
Report Includes
26 data tables and 53 additional tables
An overview of the global market for RNAi technologies
Analysis of global market trends, featuring revenue data for 20212023, estimated figures for 2024, forecasts for 2029, and projected CAGRs through 2029
Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by type, therapeutic area, delivery method, and region
A look at innovations, technological advances, and recent product launches in the RNAi market
Analysis of the industry’s regulatory framework and policies
A discussion of ESG challenges and ESG practices in the RNAi technologies industry
An analysis of the key companies’ market shares, proprietary technologies, and strategic alliances
Company profiles of major players within the industry, including Alnylam Pharmaceuticals Inc., Novartis AG, Thermo Fisher Scientific Inc., and Revvity Inc.
Companies Mentioned
ALNYLAM PHARMACEUTICALS INC.
ARROWHEAD PHARMACEUTICALS INC.
ARBUTUS BIOPHARMA CORP.
BAYER AG
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
OLIX PHARMACEUTICALS INC.
QIAGEN
REVVITY INC.
SILENCE THERAPEUTICS
SIRNAOMICS
SYLENTIS S.A.
SWITCH THERAPEUTICS
THERMO FISHER SCIENTIFIC INC.
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Chapter 2 Market Overview
- Background: Genetic Material
- RNA Interference Overview
- RNA Interference: Mechanism of Action
- Initiation Phase
- Effector Phase
- Small Interfering RNAs (siRNAs)
- MicroRNAs (miRNAs)
- Small Hairpin RNAs (shRNAs)
- Chapter 3 Market Dynamics
- Global Market Dynamics
- Market Drivers
- Increasing Prevalence of Chronic Disease
- Increasing Approval of RNAi Products
- Advancements in RNAi Delivery Systems
- Increasing Strategic Initiatives
- Convenient Dosing
- Market Restraints
- High Treatment Costs
- Lack of Awareness
- Market Opportunities
- Expansion of Disease Targets
- Combination Therapies
- Untapped Genetic Targets
- Chapter 4 Emerging Technologies and Developments
- Therapeutics
- Diagnostics
- Circulating miRNA Diagnostics for Non-invasive Health Monitoring
- Agriculture
- Chapter 5 Pipeline Analysis
- Chapter 6 Patent Analysis
- Patent Analysis
- Chapter 7 Market Segmentation Analysis
- Segmentation Breakdown
- Overview
- Market Analysis by Technology
- Therapeutics
- RNAi Therapeutics Market, by Region
- RNAi Therapeutics Market, by Therapeutic Area
- RNAi Therapeutics Market, by Delivery Method
- Diagnostics
- Reagents and Tools
- Agriculture
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Emerging Markets
- Chapter 8 Competitive Intelligence
- Strategic Initiatives
- Competitive Analysis
- Chapter 9 Sustainability in RNAi Technology Market: An ESG Perspective
- Introduction to ESG
- Sustainability in RNAi Technology Industry: An ESG Perspective
- Environmental Initiatives
- Social Initiatives
- Governance Initiatives
- Case Study
- Concluding Remarks from BCC
- Chapter 10 Appendix
- Methodology
- Acronyms
- Sources
- Company Profiles
- ALNYLAM PHARMACEUTICALS INC.
- ARROWHEAD PHARMACEUTICALS INC.
- ARBUTUS BIOPHARMA CORP.
- BAYER AG
- MERCK KGAA
- NOVARTIS AG
- NOVO NORDISK A/S
- OLIX PHARMACEUTICALS INC.
- QIAGEN
- REVVITY INC.
- SILENCE THERAPEUTICS
- SIRNAOMICS
- SYLENTIS S.A.
- SWITCH THERAPEUTICS
- THERMO FISHER SCIENTIFIC INC.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook